Carvedilol Tablet, Film Coated
Product Images NDC 50090-7849

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 50090-7849). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol Tab Usp Figure1)

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol Tab Usp Figure1)
A line graph showing % mortality over 21 months comparing Carvedilol to placebo. The graph has two curves, one for placebo with higher mortality and one for Carvedilol with lower mortality, indicating outcomes over time in months. A p-value of 0.0014 is shown on the graph.*
FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Tab Usp Figure2)

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Tab Usp Figure2)
A forest plot showing hazard ratios for various subgroups of patients, including gender, age, race, diabetic status, heart rate, systolic blood pressure, and use of spironolactone. The x-axis represents the hazard ratio scale, with a vertical reference line at 1.0, and each subgroup has a point estimate with horizontal confidence intervals.*
FDA Label Image

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Tab Usp Figure3)

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Tab Usp Figure3)
A line graph depicting mortality percentage over 24 months comparing Carvedilol and Placebo groups. The x-axis shows time in months, and the y-axis shows percent mortality. The Carvedilol group has consistently lower mortality than the Placebo group, with a noted statistical significance (P = 0.03).*
FDA Label Image

Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Tab Usp Figure4)

Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Tab Usp Figure4)
A forest plot chart depicting hazard ratios for various patient subgroups related to an unspecified study. The plot includes comparisons across age, gender, timing post-myocardial infarction, medication use, clinical parameters like Killip class and hypertension, and other factors such as diabetes and heart rate, with hazard ratios plotted on the x-axis.*
FDA Label Image

Carvedilol Chemical Structure (Carvedilol Tab Usp Structure)

Carvedilol Chemical Structure (Carvedilol Tab Usp Structure)
Chemical structure of carvedilol, displaying its molecular components including aromatic rings, hydroxyl groups, and an ether linkage characteristic of the active ingredient carvedilol.*
FDA Label Image

Label Image (Lbl500907849)

Label Image (Lbl500907849)
Packaged label for CARVEDILOL USP 25 mg film-coated tablets by A-S Medication Solutions. The label indicates 60 tablets per container, instructs to store below 86 degrees and protect from moisture, and displays the product NDC 50090-7849-0 with lot number 5977-0. The label includes a QR code and packaging location as Libertyville, Illinois.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.